Full-Time

Manager Forecasting

Posted on 2/6/2025

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

No salary listed

Senior

Princeton, NJ, USA + 1 more

More locations: San Diego, CA, USA

Hybrid model requires this role to work in the office three days per week on average.

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in business administration, marketing, finance or related field; MS/MBA a plus.
  • 1+ years’ experience in the pharmaceutical industry in a variety of progressively responsible Sales & Marketing positions including 5+ years in Commercial or Sales Operations with at least 2 years’ experience in forecasting.
  • Proven experience in using various analytical and forecasting methodologies that leverages historical product demand, primary and secondary research insights along with team inputs to design, build, and maintain accurate forecasting models using MS Excel and/or other forecasting applications.
  • Strong understanding of forecasting methodologies (including EPI and historical trend approaches), and quantitative techniques need to produce accurate product launch and in-line forecasts for the organization.
  • Demonstrated advanced modeling skills using MS Excel, and/or forecasting/statistical modeling software, along with reporting applications.
  • Excellent analytical reasoning, financial acumen, and problem-solving capabilities with demonstrated abilities to think creatively and strategically to solve and answer key business questions/problems.
  • Excellent interpersonal and collaborative skills, with a professional demeanor, with the ability to interact with all levels of management, colleagues within other departments and vendors.
  • Excellent communication and presentation skills with ability to present at the executive level with the capability to dive into details.
  • Ability to function independently.
  • Strong organizational and time management skills with the ability to multitask and prioritize own efforts.
Responsibilities
  • Responsible for supporting global forecasting efforts by working with commercial leadership (US, Canada and EU), brand/franchise leads, patient services and finance to develop multi-year monthly patient, unit, and revenue forecasts for products within the neuroscience or rare disease franchise, by leveraging historical product performance trends, the primary/secondary market insights, and soliciting team inputs.
  • Responsible for providing demand (patients on product, shipments, & units) and revenue estimates and projections for month-end, quarter-end and year-end performance to commercial leadership, executive team, brand leads, finance, and investor relations groups.
  • Design, build and maintain accurate, actionable, and evidenced based forecasting models and predictive methodologies/analytics.
  • Identify and incorporate novel forecast approaches and methodologies to contribute to the advancement of the forecast function at Acadia.
  • Maintain financial and manufacturing forecasts on a monthly cycle, and annually revise the long range forecast, in partnership with Finance, Marketing, Manufacturing, and Managed Markets.
  • Perform in-depth data analysis to build robust assumptions library and forecast inputs.
  • Monitor forecast accuracy and quantify impact of assumption differences and suggest corrective actions as appropriate.
  • Present and defend forecast approach, methodology, assumptions, and output to multiple levels of management.
  • Collaborate with Commercial Analysis, Insights and Operations peers on modeling, data and market research needs, communicating issues, and responding to requests from senior leadership.
  • Ensure all forecasting activities are conducted in accordance with financial and ethical compliance guidelines.
  • Other responsibilities as assigned.
Desired Qualifications
  • High-energy, detail-oriented, and self-motivated individual with a demonstrated history of strong focus on customer service, execution excellence, and great problem solving capabilities.
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these conditions while also promoting diversity and inclusion within their operations.

Company Size

501-1,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's DAYBUE is now available for treating Rett syndrome in the U.S.
  • The partnership with Neuren Pharmaceuticals strengthens Acadia's position in the rare disease market.
  • Increased focus on personalized medicine benefits Acadia's tailored CNS disorder therapies.

What critics are saying

  • A class action lawsuit could lead to financial liabilities and reputational damage.
  • Increased competition in CNS treatments may impact Acadia's market share.
  • Reliance on partnerships poses risks if collaborations face challenges or fail.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on CNS disorders with a strong pipeline of small molecule drugs.
  • The company has a unique partnership with Stoke Therapeutics for RNA-based therapies.
  • Acadia's documentary series raises awareness for Rett syndrome, enhancing its community engagement.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

2%

2 year growth

2%
Fierce Pharma
Dec 9th, 2024
Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead

Acadia Pharmaceuticals has hired Big Pharma veteran Thomas Andrew Garner as its new chief commercial officer (CCO).

MarketWatch
Nov 26th, 2024
Acadia Pharmaceuticals in Exclusive License Agreement With Saniona for SAN711

Acadia Pharmaceuticals on Tuesday said it entered into an exclusive worldwide license agreement with Saniona to develop and commercialize SAN711.

World Pharmaceuticals
Oct 17th, 2024
Acadia gets Health Canada approval for Daybue to treat Rett Syndrome

US-based biopharmaceutical company Acadia Pharmaceuticals has received Health Canada marketing authorisation for Daybue (trofinetide) to treat a rare genetic neurological disorder.

PRWeb
Aug 23rd, 2024
Global Genes' Annual Week In Rare Event Heading To Kansas City

"Week in RARE provides advocates a unique opportunity to participate in multiple events in one place to maximize their time, travel, and potential to gain benefits from their participation."

Yahoo Finance
Aug 15th, 2024
Ryan Reynolds Announces More To Parkinson'S(R) Campaign

Ryan & Tammy Reynolds (Photo: Business Wire)Acadia Parkinson's Fact Sheet-- The national disease awareness campaign aims to educate and drive conversation about recognizing and managing non-motor symptoms of Parkinson’s, including hallucinations and delusions-- Reynolds and his mother Tammy share their personal story about the impact of these symptoms on their familySAN DIEGO, August 14, 2024--(BUSINESS WIRE)--Ryan Reynolds, a world-renowned actor/entrepreneur and Parkinson’s disease advocate, with Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the launch of a multi-faceted disease education campaign, More to Parkinson’s®, to raise awareness among caregivers, patients and their care providers about a common, yet under-recognized aspect of Parkinson’s disease – Parkinson’s-related hallucinations and delusions.Notably, around half of the people living with Parkinson’s disease may develop hallucinations or delusions over the course of their disease, but up to 90% of people currently do not proactively tell their physicians about these symptoms.1-3 By sharing their experiences caring for Ryan’s father, James "Jim" Reynolds, who passed away nearly a decade ago, Ryan and his mother Tammy, aim to raise awareness, educate and drive conversation between people with Parkinson’s disease, their families and their doctors about how best to talk about and treat these non-motor symptoms."My father experienced hallucinations and delusions. At the time, we didn’t know any of these types of symptoms were part of his Parkinson’s disease," Reynolds explains. "Like a lot of caregivers, my mom mostly tried to carry these burdens alone. I wish I’d known Parkinson’s disease wasn’t limited to only motor symptoms. I think people and families affected by Parkinson’s can be better prepared to manage hallucinations and delusions if they’re talking early and often about this lesser-known aspect of the disease."This press release features multimedia

INACTIVE